Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

Inclusion Criteria: * Boston Scientific device with HeartLogic enabled * Lack of standard contraindications to Sacubitril/valsartan: * history of ACE-inhibitor induced angioedema and in those with angiotensin II receptor blocker (ARB) therapy induced angioedema. * hypotension, hypovolemia * renal artery stenosis, renal failure * hyperkalemia * hepatic disease Child-Pugh class C * Pregnancy/Breast-feeding * Lack of standard contraindications to diuretic therapy * Systolic Blood Pressure \> 105 Exclusion Criteria: * Glomerular filtration rate \<25 mL/min who are non-responsive to diuretic therapy or are on chronic renal dialysis * ongoing symptoms of heart failure decompensation (increased dyspnea and/or fatigue, for purposes of this study increased weight is not considered, see question 2 KCCQ). * recent significant change in arrhythmia burden (within the past 2 weeks) * in cardiac resynchronization therapy (CRT) patients, recent change (60 days) in effective delivery of CRT (eg. decreased biventricular paving %) * the subject is unable to sign or refuses to sign the patient informed consent * Symptomatic heart failure at rest or New York Heart Association Class IV at the time of enrollment * the subject is implanted with unipolar right atrial or right ventricular leads * subject has received or is scheduled to receive a heart transplant or ventricular assist device within the next 6 months * subject is pregnant or planning to become pregnant during the study * regularly scheduled IV heart failure therapy (e.g. inotropes or diuretics)